NYSE · MUX

McEwen Inc.

$17.17 -$0.42 (-2.39%) 1D After hours

Key Metrics

$1.05B
Market cap
26.50×
P/E · TTM
$38.35M
Revenue · TTM
$39.65M
Net income
EPS · TTM $0.74
Dividend yield
Free cash flow
Beta · 1Y 2.18
EBITDA · TTM
Gross margin 55.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 17
    From its Mar 2 high, the share price fell 42%.

    Peak close $28.41 on Mar 2; trough close $16.37 on Jul 17. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -42%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 5
    The stock moved -13.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 5
  • Jan 30
    The stock moved -12.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jan 30

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.05B
Enterprise value$1.11B
Shares outstanding59.7M
52-wk range$9.82 – $29.70
Avg volume · 20D641.7K
Net cash −$56.29M
Book value / share$12.24
IndustryGold And Silver Ores
ExchangeNYSE
About McEwen Inc.
IPO dateMay 7, 1980
Employees1425

McEwen Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E26.50
P/S27.40
P/FCF
EV/EBITDA
EV/Sales28.87
Graham №$14.32

Profitability

Gross 55.9%
Operating 105.7%
Net 103.4%
FCF
ROE / ROIC 6.1% · —

Financial Health

Current ratio1.14
Quick ratio0.81
Debt / equity0.19
Debt / EBITDA
Net cash −$56.29M
Working capital$13.15M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

0.4
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$14.32 vs $17.17
Trades 1.2× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings